Açık Akademik Arşiv Sistemi

Low molecular weight heparin treatment of acute moderate and severe pancreatitis: A randomized, controlled, open-label study

Show simple item record

dc.contributor.authors Tozlu, M; Kayar, Y; Ince, AT; Baysal, B; Senturk, H;
dc.date.accessioned 2020-02-27T08:28:31Z
dc.date.available 2020-02-27T08:28:31Z
dc.date.issued 2019
dc.identifier.citation Tozlu, M; Kayar, Y; Ince, AT; Baysal, B; Senturk, H; (2019). Low molecular weight heparin treatment of acute moderate and severe pancreatitis: A randomized, controlled, open-label study. TURKISH JOURNAL OF GASTROENTEROLOGY, 30, 87-81
dc.identifier.issn 1300-4948
dc.identifier.uri https://doi.org/10.5152/tjg.2018.18583
dc.identifier.uri https://hdl.handle.net/20.500.12619/66069
dc.description.abstract Conclusion: Low molecular weight heparin treatment is safe and provides better prognosis in MSAP.
dc.language English
dc.publisher AVES
dc.rights info:eu-repo/semantics/openAccess
dc.rights.uri http://creativecommons.org/licenses/by/4.0/
dc.subject Gastroenterology & Hepatology
dc.title Low molecular weight heparin treatment of acute moderate and severe pancreatitis: A randomized, controlled, open-label study
dc.type Article
dc.identifier.volume 30
dc.identifier.startpage 81
dc.identifier.endpage 87
dc.contributor.department Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor Tozlu, Mukaddes
dc.relation.journal TURKISH JOURNAL OF GASTROENTEROLOGY
dc.identifier.wos WOS:000462165400013
dc.identifier.doi 10.5152/tjg.2018.18583
dc.identifier.eissn 2148-5607
dc.contributor.author Tozlu, Mukaddes
dc.contributor.author Yusuf Kayar
dc.contributor.author Ali Tuzun Ince
dc.contributor.author Birol Baysal
dc.contributor.author Hakan Senturk


Files in this item

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/openAccess Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess